Clinical Use of Anti-CD25 Antibody Daclizumab to Enhance Immune Responses to Tumor Antigen Vaccination by Targeting Regulatory T cells
Andrew J. Rech, Robert H. VonderheideVolume:
1174
Year:
2009
Language:
english
Pages:
8
DOI:
10.1111/j.1749-6632.2009.04939.x
File:
PDF, 177 KB
english, 2009